Citation: | DING Xiying, JI Xiaolong, LI Bo, MAO Baiyang, YAN Fang, DI Bin. Determination of potential genotoxic impurity in ecabet sodium active pharmaceutical ingredient by HPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2018, 49(3): 317-321. DOI: 10.11665/j.issn.1000-5048.20180310 |
[1] |
Looker AR,Ryan MP,Neubertlangille BJ,et al.Risk assessment of potentially genotoxic impurities within the framework of quality by design[J].Org Process Res Dev,2010,14(4):1032-1036.
|
[2] |
Ma L,Ma YN,Chen Z,et al.Structural alerts of genotoxic impurities[J].Chin New Drugs J(中国新药杂志),2014,23(18):2106-2111.
|
[3] |
Wu YF,Luan Y,Qi XM,et al.Advance in study on early and rapid assays of genotoxicity[J].Drug Eval Res(药物评价研究),2011,34(4):244-250.
|
[4] |
Wang XJ,Ma J.Research advances of new techniques and methods for drug safety evaluation[J].Chin J Pharm(中国医药工业杂志),2017,48(3):341-350.
|
[5] |
Wichard JD.In silico prediction of genotoxicity[J].Food Chem Toxicol,2017,106:595-599.
|
[6] |
Bhavani KG, Krishna KBM, Srinivasu N, et al. Determination of genotoxic impurity in atazanavir sulphate drug substance by LC-MS[J].J Pharm Biomed Anal,2017,132:156-158.
|
[7] |
Wollein U, Schramek N. Simultaneous determination of alkyl mesilates and alkyl besilates in finished drug products by direct injection GC/MS[J].Eur J Pharm Sci,2012,45(1/2):201-204.
|
[8] |
Grigori K,Loukas YL,Malenovi'c A,et al.Chemometrically assisted development and validation of LC-MS/MS method for the analysis of potential genotoxic impurities in meropenem active pharmaceutical ingredient[J].J Pharm Biomed Anal,2017,145:307-314.
|
[9] |
Zhou J,Xu J,Zheng XY,et al.Determination of methyl methanesulfonate and ethyl methanesulfonate in methanesulfonic acid by derivatization followed by high-performance liquid chromatography with ultraviolet detection[J].J Sep Sci,2017,40(17):3414-3421.
|
[10] |
Ito Y,Onoda Y,Nakamura S,et al.Effects of the new anti-ulcer drug ecabet sodium(TA-2711)on pepsin activity.II.Interaction with substrate protein[J].Jpn J Pharmacol,1993,62(2):175-181.
|
[11] |
Ito Y,Shibata K,Hongo A,et al.Ecabet sodium,a locally acting antiulcer drug,inhibits urease activity of Helicobacter pylori[J].Eur J Pharmacol,1998,345(2):193-198.
|
[12] |
Murata H,Kawano S,Tsuji S,et al.Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer:prospective randomized multicenter study[J].J Gastroenterol Hepatol,2003,18(9):1029-1033.
|
[13] |
Liu GJ,Pei ZD,Zhang JX,et al.Determination of contents and related substances of ecabet sodium granules by HPLC[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(1):70-72.
|
[14] |
Zhang D,Du X,Liu M,et al.Determination of ecabet in human plasma by high-performance liquid chromatography-tandem mass spectrometry[J].J Chromatogr B,2008,863(2):223-228.
|
[15] |
Ruan XL,Zheng XY,Xu J,et al.Advances in analytical techniques for the determination of genotoxic impurities in pharmaceuticals[J].J China Pharm Univ(中国药科大学学报),2016,47(3):267-274.
|
1. |
刘艳,温田田,孙野,陈庆山,张丽莉,匡海学,杨炳友. 白鲜皮化学成分研究. 中成药. 2025(03): 812-821 .
![]() | |
2. |
陈禹竹,徐晓敏,刘树民,卢芳. 白鲜皮及其有效成分的药理作用研究进展. 药物评价研究. 2024(02): 409-418 .
![]() | |
3. |
刘新月,陈乐乐,孙鹏,展照双,王加锋. 白鲜皮化学成分、药理作用和毒性研究进展及质量标志物预测分析. 中国新药杂志. 2023(08): 799-805 .
![]() | |
4. |
牛晨冬,郭丽娜,张金玲,卢宜然,王琳琳,李宗锴. 白鲜属植物化学成分与药理作用研究进展. 中成药. 2022(04): 1231-1238 .
![]() | |
5. |
葛翎,路露,周谦,张秋生,蔡波,黄晓德,张峰伦,钱雪,李海涛,陈斌,曹鹏. 马齿苋醇提物体外生物学活性测定. 中国野生植物资源. 2021(04): 8-14+21 .
![]() | |
6. |
梁郭智,孙淑英. 白鲜研究进展. 时珍国医国药. 2020(02): 408-411 .
![]() | |
7. |
胡玉恒,孙捷,杨洁,王晓静. 3-(4′-苯甲酰基氨基-苯基)-香豆素衍生物的合成及体外降血糖活性. 中国药科大学学报. 2019(02): 168-174 .
![]() |